Kenvue, the Company Behind Tylenol, Tries to Navigate Its Latest Crisis NYT | Top Stories By: Rebecca Robbins 23 September 2025 at 04:10 Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism. © Brendan McDermid/ReutersKenvue, a spinoff of Johnson & Johnson, debuted at the New York Stock Exchange in 2023.
Login
